Serum cholesterol binding reserve percentage in diabetes mellitus

Acta Diabetologica - Tập 22 - Trang 253-258 - 1985
Ashim Ghatak1, Kul Bhushan Bhatia1, Ashok Chandra1, Narinder Kumar Kapoor1
1Division of Biochemistry, Central Drug Research Institute, Department of Medicine, K.G. Medical College, Lucknow

Tóm tắt

Serum cholesterol binding reserve percentage (SCBR%) in patients with diabetes mellitus (22.17±13.40%) was significantly lower than in controls (40.93±8.69%) (p<0.001). SCBR% of controls did not vary with age (age range 20.80 years). SCBR% declined significantly with increasing duration of diabetes. It also decreased with macrovascular complications and was lowest in multiple/fatal complications further corroborating the value of SCBR% as a risk indicator of atherogenesis. The relationship of SCBR% with treatment was very striking. All adequately controlled patients had a significantly higher SCBR% than those who were poorly controlled regardless of treatment modality and those adequately controlled on insulin had the highest SCBR%, which was close to that of normal controls.

Tài liệu tham khảo

Bondjers G., Bjorkerud S.: Cholesterol transfer between arterial smooth muscle tissue and serum lipoproteinsin vitro — Artery1, 3–9, 1974. Borreson A. L., Berg K., Dahlen G., Gillinas T., Ericson C.: Effect of gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC) — Artery9, 77–86, 1981. Borreson A. L., Berg K.: Serum reserve cholesterol binding capacity (SRCBC): the relative importance of lipoprotein classes — Artery9, 96–119, 1981. Chandra A., Gupta S., Bhatia K. B., Kapoor N. K.: Serum cholesterol binding reserve in young myocardial infarction. Proceedings of the World Congress on Coronary Heart Disease, Bombay, Feb. 1982. Chandra R., Singh R., Kumar S., Srivastava D. K.: Serum cholesterol binding reserve in some coronary artery disease risk cases — Indian Heart J.32, 355, 1980. Chandra R., Singh R., Srivastava D. K., Gupta A. K.: Study of serum cholesterol binding reserve in some coronary artery disease risk cases — J.A.P.I.30, 601, 1982. Gupta S.: Serum cholesterol binding reserve. A study of premature atherosclerosis in young patients with myocardial infarction. Thesis submitted to Lucknow University, 1981. Hsia S. L., Chao Y.-S., Hennekens C. H., Reader W. B.: Decreased serum cholesterol-binding reserve in premature myocardial infarction — Lancetii, 1000, 1975. Hsia S. L., Fishman L. M., Briese F. W., Chistakis G., Burr J., Bricker L. A.: Decreased serum cholesterol binding reserve in diabetes mellitus — Diabetes Care1, 89–93, 1978. Marble A., Camerini-Davalos R.: Clinical experience with sulfonylurea compounds in diabetes — Ann. N.Y. Acad. Sci.71, 293–248, 1957. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance — Diabetes28, 1039, 1979. Stein Y., Glanceaud M. C., Fainaru M., Stein O.: The removal of cholesterol from aortic smooth muscle cells in culture and landschutz ascites cells by fractions of human high-density apolipoprotein — Biochim. biophys. Acta (Amst.)380, 106, 1975. Zlatkis A., Zake B., Boyle A. J.: A new method for the direct determination of serum cholesterol — J. Lab. clin. Med.41, 486, 1953.